Why Partner?

With pharma and biotech doubling down on structure-based drug design to de-risk early discovery, there has never been a better time to showcase your expertise. Investment in AI-driven protein structure prediction, high-resolution structural techniques, and integrative computational approaches is unlocking new possibilities for challenging and undruggable targets and accelerating the development of novel therapeutics across small molecules, biologics, peptides, and RNA-based drugs.

As AI continues to advance, the need for experimental validation and high-quality structural insights is greater than ever—driving increased demand for cutting-edge technologies, services, and solutions that enable faster, more precise drug discovery.

The Structure-Based Drug Design Summit is your chance to connect with decision-makers actively investing in structure-based approaches, computational drug design, and enabling technologies. Across three days of targeted discussions, you’ll have the opportunity to elevate your brand, forge key partnerships, and position your solutions at the heart of the next wave of drug discovery innovation.

Don’t miss out on your opportunity to be at the forefront—partner with us and showcase how your technology or services are shaping the future of structure-based drug design.